“I am deeply troubled by the contamination incident at NIH. We rely on NIH as our premiere medical research agency to conduct its work safely and effectively, and this episode raises concerns about whether proper protocols are in place to guarantee patient safety. Our number one priority should be the health of the patients who may have received contaminated injections, and I am encouraged that NIH is taking the necessary steps to monitor those individuals. I hope that NIH and the Food and Drug Administration (FDA) are working together to identify what went wrong, and I look forward to receiving regular updates from both agencies as they ensure the safety of future research."
ORGANIZATIONS IN THIS STORY
ORGANIZATIONS IN THIS STORY